High S100A9 levels in peripheral blood monocytes and a lower ratio of CD4+ T cells/monocyte was previously found to correlate positively with poor response to anti-PD-1 immunotherapy but inversely with overall survival in melanoma patients (30). This evidence concerns the gene CD4 and melanoma.